Cdk5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The CDK5 gene (Cyclin-Dependent Kinase 5) encodes a proline-directed serine/threonine kinase that is predominantly active in post-mitotic neurons. CDK5 is critical for neuronal development, synaptic function, and its dysregulation contributes to tau pathology in Alzheimer's disease and neurodegeneration in PD, ALS, and HD.
| Attribute | Value |
|---|---|
| Symbol | CDK5 |
| Full Name | Cyclin-Dependent Kinase 5 |
| Chromosomal Location | 7q36.1 |
| NCBI Gene ID | 1020 |
| Ensembl ID | ENSG00000164885 |
| OMIM ID | 123831 |
| UniProt ID | Q00535 |
The CDK5 gene encodes CDK5, a 292-amino acid serine/threonine kinase. Unlike other CDKs, CDK5 is not regulated by cyclins but by neuron-specific activator proteins p35 and p39.
CDK5 is a neuronal-specific kinase essential for brain development and function:
CDK5 is expressed almost exclusively in neurons:
| Strategy | Approach | Status |
|---|---|---|
| Small molecule inhibitors | Roscovitine, Purvalanol A | Preclinical |
| p25/p35 modulators | Targeting activator cleavage | Research |
| Gene therapy | RNAi approaches | Preclinical |
The study of Cdk5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Cruz CD, et al. Cyclin-dependent kinase 5 in neurodegeneration. J Neurochem. 2022;158(4):835-848. DOI:10.1111/jnc.15567
[2] Liu SL, Wang C, Jiang H. The role of CDK5 in Alzheimer's disease. Mol Neurobiol. 2021;58(12):6401-6415. DOI:10.1007/s12035-021-02567-8
[3] Ahmed I, et al. CDK5 and tau pathology in Alzheimer's disease. J Alzheimers Dis. 2020;76(3):977-986. DOI:10.3233/JAD-200321
[4] Shukla V, et al. CDK5-mediated mitochondrial dysfunction in Parkinson's disease. Free Radic Biol Med. 2019;134:498-510. DOI:10.1016/j.freeradbiomed.2019.01.028
[5] S模lewicz J, et al. CDK5 in ALS and FTD. Neurobiol Aging. 2018;68:159.e9-159.e20. DOI:10.1016/j.neurobiolaging.2018.03.029